REMOLD-MM
A Pilot Study of Romosozumab Efficacy and Safety for the Management of Myeloma-related OsteoLytic Disease in Postmenopausal Women With Multiple Myeloma and Osteoporosis (REMOLD-MM)
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 1
- Enrollment
- 10 patients (estimated)
- Sponsors
- Memorial Sloan Kettering Cancer Center
- Tags
- Sclerostin
- Trial Type
- Treatment
- Last Update
- 2 weeks ago
- SparkCures ID
- 1461
- NCT Identifier
- NCT05775094
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.